Regulus Therapeutics Stock Forward View - Price Action Indicator
| RGLSDelisted Stock | USD 8.16 0.01 0.12% |
Regulus Stock outlook is based on your current time horizon.
The value of RSI of Regulus Therapeutics' share price is above 70 at this time indicating that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Regulus, making its price go up or down. Momentum 76
Buy Stretched
Oversold | Overbought |
Using Regulus Therapeutics hype-based prediction, you can estimate the value of Regulus Therapeutics from the perspective of Regulus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Regulus Therapeutics after-hype prediction price | USD 8.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regulus |
Regulus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Regulus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regulus using various technical indicators. When you analyze Regulus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Regulus Therapeutics Volatility | Backtest Regulus Therapeutics | Information Ratio |
Regulus Therapeutics Trading Date Momentum
| On February 01 2026 Regulus Therapeutics was traded for 8.16 at the closing time. The top price for the day was 8.18 and the lowest listed price was 8.07 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.12% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Regulus Therapeutics to competition
Regulus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regulus Therapeutics stock to make a market-neutral strategy. Peer analysis of Regulus Therapeutics could also be used in its relative valuation, which is a method of valuing Regulus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Regulus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Regulus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regulus Therapeutics shares will generate the highest return on investment. By undertsting and applying Regulus Therapeutics stock market strength indicators, traders can identify Regulus Therapeutics entry and exit signals to maximize returns.
Regulus Therapeutics Risk Indicators
The analysis of Regulus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Regulus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting regulus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.78 | |||
| Semi Deviation | 1.47 | |||
| Standard Deviation | 17.58 | |||
| Variance | 309.1 | |||
| Downside Variance | 13.54 | |||
| Semi Variance | 2.16 | |||
| Expected Short fall | (8.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Regulus Therapeutics
The number of cover stories for Regulus Therapeutics depends on current market conditions and Regulus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regulus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regulus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regulus Therapeutics Short Properties
Regulus Therapeutics' future price predictability will typically decrease when Regulus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regulus Therapeutics often depends not only on the future outlook of the potential Regulus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regulus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.3 M | |
| Cash And Short Term Investments | 75.8 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Regulus Stock
If you are still planning to invest in Regulus Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regulus Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |